Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,218.00
(
1.73%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
98.23
(
1.56%
)
Bitcoin
77,972.74
(
-0.34%
)
News Focus
News Focus
Post# of 517499
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Amatuer17

Send PM Follow Ignore
Followers 77
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Amatuer17

Re: XenaLives post# 257301

Thursday, 07/02/2020 4:36:12 PM

Thursday, July 02, 2020 4:36:12 PM

Post# of 517499
Majority of the CNS disease are same - difficult to treat - so no one can be so confident to say that it will be 100% success.

PDD is 1st trial so higher chance of failure.
Look at ZYNE - great P2 results - was considered slam dunk for P3 and they were talking about registration - but it failed.

So I am optimistic as I do not want to lose money but expect 50%+ chance of failure
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News